My logic is very simple, as more patients buying Pona and the drug work really well for them, it will become more popular, and more patients will move to Pona. I believe that it's the population that dictate the drug line, not FDA or some other authority.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.